Personalized Tirzepatide+

Tirzepatide is a dual GIP and GLP-1 receptor agonist. It helps regulate blood sugar, improve insulin release, and reduce appetite.
‍

Eligibility:
Patients with a BMI of 30+, or 27+ with a weight-related condition (such as type 2 diabetes, high blood pressure, or high cholesterol), may qualify. Patients with a BMI above 25 may also qualify depending on their medical history.
‍

Provider Review:
Licensed providers review your intake asynchronously — meaning no live doctor visit is required. If needed, they may follow up through the secure patient portal to request additional information. Your provider will adjust your dose over time to help maximize results with minimal side effects.
‍

Process:

1. Complete your intake form securely online.
2. A licensed provider reviews your medical history asynchronously (typically within 24 hours).
3. If approved, your medication is compounded and shipped via UPS 2-Day Air.
   
   

Expectations:

• In the first few weeks, many patients notice reduced appetite and cravings.
• By 8–12 weeks, studies show meaningful weight loss and improved blood sugar control.
• At 6 months, most patients experience significant progress, with ongoing provider guidance to adjust dosage and support long-term results.

Pricing is shared after intake once eligibility is confirmed. Current offers are as low as $258/month for patients new to GLP-1 treatment on the 6-month plan. Subscriptions are billed monthly, quarterly, or 6-month and automatically renew until the end of your six-month prescription. Pricing may vary based on plan commitment length and promotional offers.